Medivie Therapeutic Stock Shares Owned By Insiders
| MDVI Stock | ILA 52.70 1.30 2.41% |
Medivie Therapeutic fundamentals help investors to digest information that contributes to Medivie Therapeutic's financial success or failures. It also enables traders to predict the movement of Medivie Stock. The fundamental analysis module provides a way to measure Medivie Therapeutic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medivie Therapeutic stock.
Medivie |
Medivie Therapeutic Company Shares Owned By Insiders Analysis
Medivie Therapeutic's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Medivie Therapeutic Shares Owned By Insiders | 72.29 % |
Most of Medivie Therapeutic's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medivie Therapeutic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 72% of Medivie Therapeutic are shares owned by insiders. This is 376.24% higher than that of the Healthcare sector and notably higher than that of the Medical Instruments & Supplies industry. The shares owned by insiders for all Israel stocks is notably lower than that of the firm.
Medivie Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medivie Therapeutic's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medivie Therapeutic could also be used in its relative valuation, which is a method of valuing Medivie Therapeutic by comparing valuation metrics of similar companies.Medivie Therapeutic is currently under evaluation in shares owned by insiders category among its peers.
Medivie Fundamentals
| Return On Equity | -1.56 | |||
| Return On Asset | -1.09 | |||
| Operating Margin | (24.81) % | |||
| Current Valuation | 47.6 M | |||
| Shares Outstanding | 2.88 M | |||
| Shares Owned By Insiders | 72.29 % | |||
| Price To Book | 10.59 X | |||
| Price To Sales | 71.11 X | |||
| Revenue | 491 K | |||
| Gross Profit | (603 K) | |||
| EBITDA | (5.16 M) | |||
| Net Income | (6.59 M) | |||
| Cash And Equivalents | 4.15 M | |||
| Cash Per Share | 1.44 X | |||
| Total Debt | 3.19 M | |||
| Debt To Equity | 0.85 % | |||
| Current Ratio | 0.65 X | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (3.88 M) | |||
| Earnings Per Share | (4.53) X | |||
| Number Of Employees | 11 | |||
| Beta | -0.32 | |||
| Market Capitalization | 4.32 B | |||
| Total Asset | 12.19 M | |||
| Retained Earnings | (121 M) | |||
| Net Asset | 12.19 M |
About Medivie Therapeutic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medivie Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medivie Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medivie Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medivie Stock
Medivie Therapeutic financial ratios help investors to determine whether Medivie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medivie with respect to the benefits of owning Medivie Therapeutic security.